STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

AMRX AMNEAL INTERMEDIATE INCORPORATED StockScouter® Report

7

StockScouter® Score

AMNEAL INTERMEDIATE INCORPORATED, a mid cap value company in the healthcare sector, is expected to outperform the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated rapidly compared to earnings growth in the past three years. Positive
  • The multi-period measure of relative price change and consistency is well above average. Positive

 

Concerns

  • An executive, director or major shareholder sold a large number of shares recently. Negative
  • Short-term relative price momentum exhibits moderate weakness. Neutral/Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be out of favor, value stocks will be out of favor, and healthcare stocks will be out of favor.

Expected Risk/Return

Progress: 40% done.
Progress: 100% done.
Low
High

Core Model Grades

A
D
C
A

Previous Ratings

9
8
8